The development of a highly advanced comprehensive risk test by Genetic Technologies is a significant step in personalized healthcare, which has garnered positive investor sentiment, leading to a rise in its stock price. This innovation could potentially open up new markets and revenue streams for the company, making it a critical development for investors to watch.